Aarey Drugs & Pharmaceuticals released its Q1 FY26 unaudited financial results, showing a 19.48% decrease in total income to Rs. 1,037.60 lakhs. Despite lower revenue, profit after tax increased by 10.81% to Rs. 13.73 lakhs. Basic EPS improved by 9.09% to Rs. 0.48. The company maintained profitability despite revenue decline, suggesting effective cost management. The results were approved by the Board of Directors and reviewed by auditors.